GB739800A - Aqueous pharmaceutical solutions of reserpine for parenteral administration - Google Patents

Aqueous pharmaceutical solutions of reserpine for parenteral administration

Info

Publication number
GB739800A
GB739800A GB712455A GB712455A GB739800A GB 739800 A GB739800 A GB 739800A GB 712455 A GB712455 A GB 712455A GB 712455 A GB712455 A GB 712455A GB 739800 A GB739800 A GB 739800A
Authority
GB
United Kingdom
Prior art keywords
reserpine
parenteral administration
aqueous pharmaceutical
pharmaceutical solutions
mgs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB712455A
Inventor
Emil Schlittler
Johannes Mueller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Priority to GB712455A priority Critical patent/GB739800A/en
Publication of GB739800A publication Critical patent/GB739800A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An aqueous pharmaceutical preparation for parenteral administration comprises reserpine and ascorbic acid with the optional addition of sodium ascorbate. The proportions by weight of reserpine are 0.01 to 1 per cent; of ascorbic acid 5 to 20 and preferably 10, per cent; and of sodium ascorbate 1 to 2 per cent. For a single dose the quantity of reserpine is 0.1 to 10 mgs.; ascorbic acid 50 to 200, and preferably 100 mgs.; and sodium ascorbate is 10 to 20 mgs. Specification 737,310 is referred to.
GB712455A 1954-10-19 1954-10-19 Aqueous pharmaceutical solutions of reserpine for parenteral administration Expired GB739800A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB712455A GB739800A (en) 1954-10-19 1954-10-19 Aqueous pharmaceutical solutions of reserpine for parenteral administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB712455A GB739800A (en) 1954-10-19 1954-10-19 Aqueous pharmaceutical solutions of reserpine for parenteral administration

Publications (1)

Publication Number Publication Date
GB739800A true GB739800A (en) 1955-11-02

Family

ID=9827083

Family Applications (1)

Application Number Title Priority Date Filing Date
GB712455A Expired GB739800A (en) 1954-10-19 1954-10-19 Aqueous pharmaceutical solutions of reserpine for parenteral administration

Country Status (1)

Country Link
GB (1) GB739800A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2854380A (en) * 1955-09-06 1958-09-30 Upjohn Co Aqueous therapeutic composition comprising reserpine, propylene glycol and sorbitol
DE1159130B (en) * 1960-09-20 1963-12-12 Dresden Arzneimittel Process for the stabilization of reserpine solutions
DE1182389B (en) * 1960-09-19 1964-11-26 Dresden Arzneimittel Method for stabilizing ajmaline solutions
DE1183201B (en) * 1961-02-21 1964-12-10 Dresden Arzneimittel Process for the stabilization of Rauwolfia alkaloid solutions
DE1248233B (en) * 1959-07-15 1967-08-24 Ciba Geigy Process for the preparation of injection solutions
DK152415B (en) * 1980-02-26 1988-02-29 Braas & Co Gmbh DEVICE FOR MANUFACTURING PROFILED, PLATFORMED ARTICLES, PRIOR TO THE TAX OF CONCRETE OR SIMILAR MATERIAL

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2854380A (en) * 1955-09-06 1958-09-30 Upjohn Co Aqueous therapeutic composition comprising reserpine, propylene glycol and sorbitol
DE1248233B (en) * 1959-07-15 1967-08-24 Ciba Geigy Process for the preparation of injection solutions
DE1182389B (en) * 1960-09-19 1964-11-26 Dresden Arzneimittel Method for stabilizing ajmaline solutions
DE1159130B (en) * 1960-09-20 1963-12-12 Dresden Arzneimittel Process for the stabilization of reserpine solutions
DE1183201B (en) * 1961-02-21 1964-12-10 Dresden Arzneimittel Process for the stabilization of Rauwolfia alkaloid solutions
DK152415B (en) * 1980-02-26 1988-02-29 Braas & Co Gmbh DEVICE FOR MANUFACTURING PROFILED, PLATFORMED ARTICLES, PRIOR TO THE TAX OF CONCRETE OR SIMILAR MATERIAL

Similar Documents

Publication Publication Date Title
GB1405088A (en) Slow release formulation
GB1262785A (en) Improvements in or relating to phloroglucinol derivatives
GB739800A (en) Aqueous pharmaceutical solutions of reserpine for parenteral administration
ES410825A1 (en) Quinoline derivatives
ES296176A1 (en) A new compound of hydrogiretinic acid of drug activity and its manufacturing procedure (Machine-translation by Google Translate, not legally binding)
ES294928A1 (en) A procedure to prepare a liquid and stable composition of tetracycline (Machine-translation by Google Translate, not legally binding)
GB818248A (en) Improvements in and relating to the production of adrenocorticotrophin preparation of enhanced stability
GB1360032A (en) 2-thio-5-azocytosine and its nucleosides
GB1029050A (en) Improvements in and relating to new flavone and the process of preparation and application thereof
GB1217135A (en) Daunomycin derivatives
GB908634A (en) Pharmaceutical compositions containing pararosaniline or derivatives thereof
GB1342643A (en) Thioacetanilide derivatives
GB950663A (en) ª‰-(ú¿ª‰-n,n-diethylaminoethoxy)ethyl ª‰, ª‰-diphenyl-ª‡-methylpropionate and acid addition salts thereof
GB1298057A (en) Bis(aminoalkylsulphamoyl)anthraquinones
GB1490247A (en) Process for preparing mono-and di-esters of 2,5-dihydroxybenzene sulphonic acid
GB1364318A (en) Laurotetanine derivatives
GB1007014A (en) Improvements in or relating to sulphonamides
ES340743A1 (en) Piperazine di-(n-acetyl-glycinate)
GB1448421A (en) Di-hydroxygenzenesulphonic acid salts
ES458413A1 (en) Pharmaceutical composition
ES345113A1 (en) Oxyalkanoic benzofuran derivatives
ES249787A1 (en) Improvements in or relating to phenothiazine derivatives
GB806908A (en) Improvements in or relating to new aqueous solutions of monosemicarbazone of adrenochrome
GB956231A (en) Improvements in or relating to derivatives of nitrofuran
ES390501A1 (en) 3-(5-nitro-2-thienyl)-1-oxa-2,4-diazaspiro(4,5)-dec-2-ene